Activated small interfering RNA (siRNA) microneedles for pathological scar treatment
A Singapore institute of higher learning has developed a world-first clinically effective and pain-free treatment of pathological scars using topical small interfering RNA (siRNA) microneedles. This patented technology comprises of a dissolvable microneedle containing activated siRNA for scar treatment. The team is currently working towards clinical trials. The technology provider is interested in licensing or commercial partnerships with technical assistance with MNEs/SMEs.